NYSE
MOH
Last Price
US $205.71
KEY FIGURES
MKT CAP
$10.7B
EPS
TTM
$-0.14
EPS Growth (1Y)
-56.32%
PEG
TTM
N/M
P/E
TTM
N/M
P/S
TTM
0.24x
YIELD
-
GROWTH (5Y CAGR)
Revenue
18.52%
EBITDA
Cash Flow (DCF)
Fair Value
Market $205.71
—
Default assumptions
EBITDA Multiple
Fair Value
Market $205.71
-33.46%
Default assumptions
Valuation
Financial
Performance
Cash flow to debt coverage
Molina Healthcare, Inc. cash flow to debt ratio of -13.54% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.
Free cash flow growth
Molina Healthcare, Inc.'s free cash flow has decreased 216.91% from $544.00M last year to $-636.00M, signaling decreasing performance
Debt-to-equity ratio
Molina Healthcare, Inc.'s debt to equity ratio is 0.95, which means that the company's assets are unhealthy financed, signaling financial risk.
Debt-to-equity trend
Molina Healthcare, Inc.'s debt has increased relative to shareholder equity from 0.69 last year to 0.95 today, signaling weakened financials
Net debt to EBITDA
Molina Healthcare, Inc. has a net cash position, so leverage is healthy.
Interest coverage
Molina Healthcare, Inc.'s interest coverage ratio is 1.42, which means that the company struggles to meet interest obligations, signaling financial risk.
Profit margin growth
Molina Healthcare, Inc.'s profit margin has decreased (100.54%) in the last year from 2.90% to -0.02%, signaling decreasing performance
Current ratio
Molina Healthcare, Inc.'s short-term assets of $12.44B exceed its short-term liabilities of $7.37B
Return on assets
Molina Healthcare, Inc.'s return on assets of -0.04% is lower than the 5.00% threshold, indicating inefficient asset utilization
Return on equity
Molina Healthcare, Inc.'s return on equity of -0.17%, is lower than 15.00%, indicating bad performance
Earnings quality
Molina Healthcare, Inc.'s operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation
Earnings stability
Molina Healthcare, Inc. had positive net income in 5 out of 5 years, indicating stable and consistent earnings
Positive free cash flow
Molina Healthcare, Inc. has negative free cash flow, indicating the company is burning cash rather than generating it
Free cash flow yield
Molina Healthcare, Inc. has negative free cash flow, indicating cash burn
Earnings growth
Molina Healthcare, Inc.'s yearly earnings has decreased 59.97% since last year from $1.18B to $472.00M, signaling decreasing performance
Revenue growth
Molina Healthcare, Inc.'s yearly revenue has increased 11.75% since last year from $40.65B to $45.43B, signaling increasing performance
Return on invested capital
ROIC 3.52% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.
3-year revenue CAGR
Molina Healthcare, Inc.'s 3-year revenue CAGR of 12.42% is positive, indicating growing revenue over the past 3 years
Revenue consistency
Molina Healthcare, Inc. had revenue growth in 5 out of 5 years, indicating consistent revenue performance
Return on equity consistency
Molina Healthcare, Inc. had positive ROE in 5 out of 5 years, indicating consistent and reliable returns on equity
Cash Flow Valuation (DCF)
Molina Healthcare, Inc. has insufficient data to evaluate this check.
Earnings yield (TTM)
Molina Healthcare, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails
EBITDA Valuation
Molina Healthcare, Inc. is overvalued relative to its fair value price of 136.88 based on EBITDA multiple model
EV/EBITDA (FY)
Molina Healthcare, Inc. has an EV/EBITDA ratio of 6.22x, which is below the 20.00x threshold, indicating reasonable valuation relative to its operating earnings
PEG ratio (TTM/FY)
Molina Healthcare, Inc.'s earnings growth over the measurement period is negative; the PEG ratio is not meaningful and the check fails.
Price-to-book ratio (FY)
Molina Healthcare, Inc. has a price-to-book ratio of 2.45x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value
Price-to-sales ratio (TTM)
Molina Healthcare, Inc. has a price-to-sales ratio of 0.23x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue
Profit margin
Current Ratio
Capital Returns
-0.17%
Return on equity
ROIC: 3.52%
Valuation History
1285.7X
Price to Earnings
EV/EBITDA: 26.2X
Cash flow
Profit margin
-3.24%
Cash flow
-
EARNINGS FV (GRAHAM)
Fair Value
Market $205.71
252.56%
Default assumptions
Base valuations use default assumptions. Customize in the Valuator.